COVID-19

August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]

September 18, 2020

September 18, 2020

September 16, 2020

September 15, 2020

September 14, 2020

September 11, 2020

September 9, 2020

September 8, 2020

September 8, 2020

September 6, 2020
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community